US Stock MarketDetailed Quotes
PRTG Portage Biotech
- 6.000
- +3.300+122.20%
Close Aug 23 16:00 ET
- 5.760
- -0.240-4.00%
Post 19:59 ET
6.29MMarket Cap-77P/E (TTM)
8.280High3.900Low49.67MVolume4.250Open2.700Pre Close317.21MTurnover8358.59%Turnover RatioLossP/E (Static)1.05MShares61.98852wk High1.56P/B3.57MFloat Cap2.08052wk Low--Dividend TTM594.23KShs Float899.526Historical High--Div YieldTTM162.20%Amplitude2.080Historical Low6.386Avg Price1Lot Size
Portage Biotech Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.42%-14.3M | 33.33%-3.12M | -26.89%-3.43M | -78.49%-12.07M | -107.95%-4.68M | -63.09%-2.7M | -97.02%-2.51M | -37.72%-2.18M | -57.89%-6.76M | -145.47%-2.25M |
| Net income from continuing operations | 27.98%-75.38M | 73.62%-24.91M | -424.97%-39.38M | -446.02%-104.67M | -965.72%-94.46M | -78.34%-7.5M | 62.29%-1.09M | 49.58%-1.63M | -11.52%-19.17M | 29.07%-8.86M |
| Operating gains losses | -3,568.08%-7.39M | -94,528.57%-6.62M | -912.38%-853K | 126.96%213K | 98.36%-7K | 229.63%105K | 30.23%56K | 118.15%59K | -177.53%-790K | -161.44%-427K |
| Depreciation and amortization | 5,300.00%54K | --13K | 1,400.00%15K | --1K | --0 | --1K | --0 | --0 | --0 | --0 |
| Deferred tax | 40.92%-10.56M | --0 | -536.83%-9.5M | -506.94%-17.88M | -409.03%-14.95M | 2,264.13%2.18M | -288.58%-2.55M | -2,209.09%-2.55M | 79.64%4.39M | 97.79%4.84M |
| Other non cash items | -182.59%-7.32M | -121.26%-6.88M | -425.19%-1.72M | -2,259.17%-2.59M | -10,463.33%-3.11M | 1,660.00%528K | -233.33%-40K | 0.00%30K | -91.16%120K | 20.00%30K |
| Change In working capital | 9,920.00%982K | 77.74%-313K | -127.35%-212K | 97.83%-10K | -164.29%-1.41M | 96.70%775K | -387.50%-115K | 302.75%736K | 38.04%-461K | -279.12%-532K |
| -Change in receivables | ---- | ---- | -106.25%-4K | ---- | ---- | -84.98%64K | -97.13%5K | 79.53%-44K | ---- | ---- |
| -Change in prepaid assets | 97.40%-32K | 60.36%-348K | 165.86%218K | -240.48%-1.23M | -114.67%-878K | -177.34%-331K | -17.03%385K | -203.55%-408K | 159.38%877K | 72.57%-409K |
| -Change in payables and accrued expense | -12.75%972K | 131.96%178K | -143.17%-430K | 191.91%1.11M | -303.28%-557K | 387.86%996K | 13.93%-513K | 318.38%1.19M | -237.73%-1.21M | -85.53%274K |
| -Change in other current assets | 66.67%40K | --39K | -83.33%4K | 114.55%24K | --0 | 116.90%24K | --0 | --0 | -358.33%-165K | ---21K |
| -Change in other working capital | -97.62%2K | ---- | ---- | 115.38%84K | 500.00%54K | -21.43%22K | ---- | ---- | --39K | --9K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.42%-14.3M | 33.33%-3.12M | -26.89%-3.43M | -78.49%-12.07M | -107.95%-4.68M | -63.09%-2.7M | -97.02%-2.51M | -37.72%-2.18M | -57.89%-6.76M | -145.47%-2.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 555.75%2.81M | 2.81M | 0 | -617K | 0 | 0 | 0 | 0 | ||
| Net PPE purchase and sale | --0 | --0 | --0 | ---3K | --0 | --0 | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | --2.81M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | ---614K | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 555.75%2.81M | --2.81M | --0 | ---617K | --0 | --0 | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 5,200.85%5.97M | -100.19%-4K | 591.82%5.33M | -100.43%-117K | 2.12M | 770K | -3,614.81%-3.01M | 0 | 474.25%27.35M | 0 |
| Net issuance payments of debt | 98.00%-40K | ---12K | ---11K | ---2M | --0 | --0 | ---2M | --0 | --0 | --0 |
| Net common stock issuance | 102.15%6.03M | 144.33%5.35M | --0 | -89.75%2.98M | --2.19M | --794K | --0 | --0 | 316.81%29.09M | --0 |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --105K | --0 |
| Net other financing activities | 98.18%-20K | -7,987.88%-5.34M | 22,341.67%5.34M | 40.66%-1.1M | ---66K | ---24K | ---- | ---- | -48.40%-1.85M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 5,200.85%5.97M | -100.19%-4K | 591.82%5.33M | -100.43%-117K | --2.12M | --770K | -3,614.81%-3.01M | --0 | 474.25%27.35M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -54.84%10.55M | -59.24%5.34M | -77.09%3.45M | 743.03%23.35M | -48.82%13.1M | -44.84%15.04M | -26.00%21.18M | 743.03%23.35M | -12.12%2.77M | 603.96%25.6M |
| Current changes in cash | 56.92%-5.52M | 87.77%-313K | 198.04%1.9M | -162.22%-12.81M | -13.68%-2.56M | -16.65%-1.93M | -352.65%-6.14M | -108.42%-2.18M | 5,487.96%20.58M | -159.63%-2.25M |
| End cash Position | -52.32%5.03M | -52.32%5.03M | -59.24%5.34M | -54.84%10.55M | -54.84%10.55M | -48.82%13.1M | -44.84%15.04M | -26.00%21.18M | 743.03%23.35M | 743.03%23.35M |
| Free cash flow | -18.39%-14.3M | 33.33%-3.12M | -26.89%-3.43M | -78.53%-12.08M | -107.95%-4.68M | -63.09%-2.7M | -97.25%-2.52M | -37.72%-2.18M | -57.89%-6.76M | -145.47%-2.25M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg